About InvAscent
InvAscent is a company based in Hyderabad (India) founded in 2005. InvAscent has completed 1 acquisition, including Symbiotec. InvAscent offers products and services including Growth Equity Capital and Portfolio Management.
- Headquarter Hyderabad, India
-
Sectors
Financial ServicesHealthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Invascent
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InvAscent
InvAscent offers a comprehensive portfolio of products and services, including Growth Equity Capital and Portfolio Management.
Growth equity capital is provided to support Indian life sciences companies
Investments in life sciences companies are managed through various funds
People of InvAscent
Unlock access to complete
Unlock access to complete
Funding Insights of InvAscent
Detailed funding history for InvAscent
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InvAscent
InvAscent has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Symbiotec.
Investment portfolio details for InvAscent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for InvAscent
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - InvAscent
Detailed financials for InvAscent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invascent Comparisons
Peer comparison for InvAscent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InvAscent
Detailed competitors of InvAscent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invascent
Complete news archive for InvAscent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InvAscent
InvAscent was founded in 2005.
InvAscent is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
InvAscent is identified as Indias leading life sciences private equity firm, having been established in 2005. Over 150 years of collective experience in life sciences are brought into the firm, with assets under management exceeding USD 850 million. A total of 38 investments have been made across four funds, and growth equity capital is provided to Indian life sciences companies. Offices are maintained in Hyderabad, Mumbai, and Gandhinagar, where collaborative partnerships are fostered to create sustained value in portfolio companies.
InvAscent offers Growth Equity Capital and Portfolio Management.
InvAscent has made 1 acquisition, including Symbiotec.